This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Sandoz Rizatriptan ODT (2016-10-12)

Starting date:
October 12, 2016
Posting date:
October 24, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-60736

Affected Products

Reason

Out of specification result for the assay during stability testing

Depth of distribution

Wholesalers and pharmacies in Canada

Affected products

Sandoz Rizatriptan ODT

DIN, NPN, DIN-HIM
DIN 02351870
Dosage form

Orally Disintegrating Tablet

Strength

5 mg

Lot or serial number

GG0804

Companies
Recalling Firm
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA

Date modified: